Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial

BACKGROUND: The Global Programme for the Elimination of Lymphatic Filariasis (GPELF) has been in operation since the year 2000, with the aim of eliminating the disease by the year 2020, following five to six rounds of effective annual mass drug administration (MDA). The treatment regimen is ivermect...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Trials
Auteurs principaux: de Souza, Dziedzom K., Ahorlu, Collins S., Adu-Amankwah, Susan, Otchere, Joseph, Mensah, Sedzro K., Larbi, Irene A., Mensah, George E., Biritwum, Nana-Kwadwo, Boakye, Daniel A.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Study Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625710/
https://ncbi.nlm.nih.gov/pubmed/28969715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2196-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires